These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 9842950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.
    Wagner KD, Ambrosini P, Rynn M, Wohlberg C, Yang R, Greenbaum MS, Childress A, Donnelly C, Deas D, Sertraline Pediatric Depression Study Group.
    JAMA; 2003 Aug 27; 290(8):1033-41. PubMed ID: 12941675
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B.
    Int Clin Psychopharmacol; 1995 Jun 27; 10(2):57-65. PubMed ID: 7673657
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial.
    Ghobadian A, Mokhtari S, Shariati B, Kamalzadeh L, Shati M, Eftekhar Ardebili M, Yarahmadi M, Shalbafan M.
    BMC Pharmacol Toxicol; 2022 Sep 27; 23(1):73. PubMed ID: 36167636
    [Abstract] [Full Text] [Related]

  • 13. Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
    Wagner KD, Cook EH, Chung H, Messig M.
    J Child Adolesc Psychopharmacol; 2003 Sep 27; 13 Suppl 1():S53-60. PubMed ID: 12880500
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
    Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C.
    J Am Acad Child Adolesc Psychiatry; 2004 Nov 27; 43(11):1387-96. PubMed ID: 15502598
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
    Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT.
    J Am Acad Child Adolesc Psychiatry; 2001 Feb 27; 40(2):222-9. PubMed ID: 11211371
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
    Geller DA, Hoog SL, Heiligenstein JH, Ricardi RK, Tamura R, Kluszynski S, Jacobson JG, Fluoxetine Pediatric OCD Study Team.
    J Am Acad Child Adolesc Psychiatry; 2001 Jul 27; 40(7):773-9. PubMed ID: 11437015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.